Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00143117 · ClinicalTrials.gov registry record · Phase 2
Assessment of Efficacy and Safety of UK-390,957 in Men With Premature Ejaculation
A Phase 2 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 2
- Development phase
- 460
- Enrollment target
NCT00143117 is a Phase 2 study that has completed, run by Pfizer. The registered enrollment target is 460 participants.
The verdict
NCT00143117, a Phase 2 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 460 participants
- Enrollment target
Study Summary
To determine whether UK-390,957 is an effective and safe treatment for premature ejaculation.
Interventions
- DRUG UK-390,957
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 460 participants |
| Start Date | 2004-08 |
| Est. Completion | 2005-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00143117
The ClinicalTrials.gov registry entry for NCT00143117 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 460 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which UK-390,957 is the first listed.
NCT00143117 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00143117 about?
NCT00143117 is a clinical study titled "Assessment of Efficacy and Safety of UK-390,957 in Men With Premature Ejaculation". To determine whether UK-390,957 is an effective and safe treatment for premature ejaculation.
What is the current status of trial NCT00143117?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 460 participants. The study started on 2004-08. Estimated completion is 2005-06.
What interventions are being tested in trial NCT00143117?
The interventions under investigation include: UK-390,957 (DRUG).
Who is sponsoring clinical trial NCT00143117?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.